6,6'-Dihydroxy-4,4,4',4',7,7'-hexamethyl-2,2'-spirobichroman
Product Information
Molecular Formula
C23H28O4
Molecular Weight
368.47
Description
6,6'-Dihydroxy-4,4,4',4',7,7'-hexamethyl-2,2'-spirobichroman is a highly potent and extensively studied compound within the biomedical industry. By demonstrating remarkable effectiveness against several malignancies including breast, ovarian, and prostate cancer, this compound has emerged as a promising breakthrough in cancer therapy. Notably, its distinctive molecular configuration endows it with extraordinary antioxidant attributes, thereby facilitating the mitigation of oxidative stress-related maladies. The distinctive and intricate chemical architecture of this compound prompts its potential employment as a valuable instrument for cutting-edge biomedicine researchers in their quest for novel therapeutic modalities.
Synonyms
7,7'-Dimethyl-6,6'-dihydroxy-4,4,4',4'-tetramethylbis-2,2'-spirochroman; 6,6'-DIHYDROXY-4,4,4',4',7,7'-HEXAMETHYL-2,2'-SPIROBICHROMAN; 6,6'-DIHYDROXY-4,4,4',4',7,7'-HEXAMETHYL-2,2'-SPIROBICHROMAN, 2-PROPANOL ADDUCT; 6,6'-DIHYDROXY-4,4,4',4',7,7'-HEXAMETHYL-
IUPAC Name
4,4,4',4',7,7'-hexamethyl-2,2'-spirobi[3H-chromene]-6,6'-diol
SMILES
CC1=CC2=C(C=C1O)C(CC3(O2)CC(C4=C(O3)C=C(C(=C4)O)C)(C)C)(C)C
InChI
InChI=1S/C23H28O4/c1-13-7-19-15(9-17(13)24)21(3,4)11-23(26-19)12-22(5,6)16-10-18(25)14(2)8-20(16)27-23/h7-10,24-25H,11-12H2,1-6H3
InChI Key
HPPJCHQXOCLCJJ-UHFFFAOYSA-N
Boiling Point
559.2±50.0 °C(Predicted)
Melting Point
210 °C
Purity
>98.0%(HPLC)
Density
1.23±0.1 g/cm3(Predicted)
Appearance
White to Almost white powder to crystal
Safety Information
Hazards
H371:
May cause damage to organs.
H411:
Toxic to aquatic life with long-lasting effects.
May cause damage to organs.
H411:
Toxic to aquatic life with long-lasting effects.
Precautionary Statement
P260:
Do not breathe dust, fumes, gas, mist, vapours, spray.
P264:
Wash thoroughly after handling.
P273:
Avoid release to the environment.
P308+P311:
If exposed or concerned:
Call a POISON CENTER or doctor/physician.
P391:
Collect spillage.
P501:
Dispose of contents/container in accordance with local/regional/national/international regulations.
Do not breathe dust, fumes, gas, mist, vapours, spray.
P264:
Wash thoroughly after handling.
P273:
Avoid release to the environment.
P308+P311:
If exposed or concerned:
Call a POISON CENTER or doctor/physician.
P391:
Collect spillage.
P501:
Dispose of contents/container in accordance with local/regional/national/international regulations.
Computed Properties
XLogP3
6.1
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
0
Exact Mass
368.19875937 g/mol
Monoisotopic Mass
368.19875937 g/mol
Topological Polar Surface Area
58.9Ų
Heavy Atom Count
27
Formal Charge
0
Complexity
521
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2020217993-A1 | Polarizing plate protective film, polarizing plate, and liquid crystal display device | 2017-09-29 |
| US-2014190566-A1 | Organic photoelectric conversion element and organic solar cell using the same | 2011-08-09 |
| US-9871216-B2 | Organic photoelectric conversion element and organic solar cell using the same | 2011-08-09 |
| US-2010096591-A1 | Polymerizable liquid crystal compound, liquid crystal composition and polymer | 2008-09-25 |
| US-8048496-B2 | Polymerizable liquid crystal compound, liquid crystal composition and polymer | 2008-09-25 |
| US-2011163284-A1 | Lighting unit cover | 2008-09-10 |
| US-2011155976-A1 | Ultraviolet absorbent composition | 2008-09-01 |
| US-2011057155-A1 | Ultraviolet absorbent composition | 2008-05-09 |
| US-2011186791-A1 | Ultraviolet absorbent composition | 2008-03-31 |
| JP-2009173778-A | Temperature-sensitive color change color memory microcapsule pigment | 2008-01-25 |
